Substance Monitoring Safer Drug Supply Program Lack of Federal Regulation Mifepristone Schedule I Drugs
AI-driven analysis of over 10,000 studies reveals strong evidence for symptom relief and potential tumor suppression, urging regulatory changes and further research.